Fouadhassan

Moderna testing 70$

Long
Fouadhassan Updated   
NASDAQ:MRNA   Moderna, Inc.
Moderna has benefit a lot from COVID time and coming with Vaccine is huge win lining the way for more products with mRNA tech , breaking 70$ it may go back up with good news on test results that, so far no major side effect found i hope they make success , this will justify easy 130$
Trade closed: target reached:
target reached at 90 , 112 and 146 closed and waiting entry back near 100 $
Trade closed: target reached:
recent target 185 reached

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.